(Q34534410)

2 August 2017

title

Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma (English)

1 reference

pancreatic ductal carcinoma

2 August 2017

1 reference

1 reference

Christine A Iacobuzio-Donahue

inferred from title

author

series ordinal

4

object named as

Christine A Iacobuzio-Donahue

1 reference

2 August 2017

6

Michael Goggins

1 reference

2 August 2017

2

Noriyoshi Fukushima

1 reference

2 August 2017

5

Charles J Yeo

1 reference

2 August 2017

Hiroyuki Matsubayashi

series ordinal

3

object named as

Hiroyuki Matsubayashi

1 reference

2 August 2017

Norihiro Sato

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

107

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

251-257

1 reference

Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Regulation of the G2/M transition by p53.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Toward maintaining the genome: DNA damage and replication checkpoints

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

The 14-3-3 cancer connection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Genomic imbalances in the progression of endocrine pancreatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Aberrant methylation of Reprimo in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Aberrant methylation of Reprimo in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Immortalization with telomerase of the Nestin-positive cells of the human pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Epigenetic inactivation of CHFR in human tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Molecular genetic alterations in ductal pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Genomic instability in Gadd45a-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21977

7 January 2021

Identifiers

DOI

10.1002/CNCR.21977

1 reference

2 August 2017

1 reference